Tropical Herbal Plants Said To Drive Vietnam’s Attraction To Foreign Investors
This article was originally published in PharmAsia News
Vietnam's pharmaceutical industry has grown to the point that the nation counted 370 foreign businesses licensed to do business in the country by the end of last October. An official of the Ministry of Planning and Investment said part of the popularity of the nation has to do with its abundance of tropical herbal plants. Among foreign investors, Chinese, Indian and Pakistani companies lead the pack. Vietnam imported $777 million worth of drugs and medicinal materials last year, a quarter of the total attributed to medicinal materials. ( Click here for more
You may also be interested in...
Gilead's remdesivir is first drug fully approved by FDA to treat COVID-19. Roche and Atea team up on an investigational direct acting antiviral while Moderna reaches the 30,000-patient enrollment target for its Phase III COVE study of the company's investigational mRNA vaccine.
From efficacy endpoints to patient warehousing, US FDA advisors weigh in on vaccine development and regulatory review.
Several years ago, heart device giant Edwards Lifesciences realized it needed a new CAPA framework that shifts corrective and preventive action from a one-size-fits-all method to a more nuanced approach. See what Dan Buehner, director of quality engineering at Edwards Lifesciences, said about it here.